KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenon Pharmaceuticals (XENE) Assets Average: 2014-2025

Historic Assets Average for Xenon Pharmaceuticals (XENE) over the last 11 years, with Sep 2025 value amounting to $641.1 million.

  • Xenon Pharmaceuticals' Assets Average fell 25.45% to $641.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $641.1 million, marking a year-over-year decrease of 25.45%. This contributed to the annual value of $881.5 million for FY2024, which is 2.56% up from last year.
  • According to the latest figures from Q3 2025, Xenon Pharmaceuticals' Assets Average is $641.1 million, which was down 9.55% from $708.8 million recorded in Q2 2025.
  • In the past 5 years, Xenon Pharmaceuticals' Assets Average ranged from a high of $941.9 million in Q1 2024 and a low of $239.9 million during Q1 2021.
  • In the last 3 years, Xenon Pharmaceuticals' Assets Average had a median value of $770.7 million in 2025 and averaged $779.7 million.
  • In the last 5 years, Xenon Pharmaceuticals' Assets Average skyrocketed by 193.69% in 2022 and then declined by 25.45% in 2025.
  • Quarterly analysis of 5 years shows Xenon Pharmaceuticals' Assets Average stood at $418.2 million in 2021, then soared by 82.93% to $765.0 million in 2022, then rose by 6.92% to $817.9 million in 2023, then dropped by 0.11% to $817.0 million in 2024, then declined by 25.45% to $641.1 million in 2025.
  • Its last three reported values are $641.1 million in Q3 2025, $708.8 million for Q2 2025, and $770.7 million during Q1 2025.